Amphastar Pharma (AMPH) Misses Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts AMPH Hot Sheet
Join SI Premium – FREE
Amphastar Pharma (NASDAQ: AMPH) reported Q4 EPS of $0.92, $0.05 worse than the analyst estimate of $0.97. Revenue for the quarter came in at $186.5 million versus the consensus estimate of $192.69 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Fubo names former Disney+ president Alisa Bowen as new CEO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
